By Ian Walker
The European Commission has started a formal investigation into animal health company Zoetis to see if it broke competition rules by preventing the launch of a competing pain medicine for dogs.
The European Commission--the EU's executive arm--said Tuesday that it plans to start an in-depth investigation as a matter of priority.
The company wasn't immediately available for comment when approached by Dow Jones Newswires.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
03-26-24 0954ET